Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1973 1
1974 1
1978 1
2010 1
2011 1
2012 2
2013 1
2014 1
2019 2
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
An immune-cell signature of bacterial sepsis.
Reyes M, Filbin MR, Bhattacharyya RP, Billman K, Eisenhaure T, Hung DT, Levy BD, Baron RM, Blainey PC, Goldberg MB, Hacohen N. Reyes M, et al. Among authors: billman k. Nat Med. 2020 Mar;26(3):333-340. doi: 10.1038/s41591-020-0752-4. Epub 2020 Feb 17. Nat Med. 2020. PMID: 32066974 Free PMC article.
Induction of a regulatory myeloid program in bacterial sepsis and severe COVID-19.
Reyes M, Filbin MR, Bhattacharyya RP, Sonny A, Mehta A, Billman K, Kays KR, Pinilla-Vera M, Benson ME, Cosimi LA, Hung DT, Levy BD, Villani AC, Sade-Feldman M, Baron RM, Goldberg MB, Blainey PC, Hacohen N. Reyes M, et al. Among authors: billman k. bioRxiv. 2020 Sep 2:2020.09.02.280180. doi: 10.1101/2020.09.02.280180. Preprint. bioRxiv. 2020. PMID: 32908980 Free PMC article.
Sustained delivery fluocinolone acetonide vitreous implants: long-term benefit in patients with chronic diabetic macular edema.
Cunha-Vaz J, Ashton P, Iezzi R, Campochiaro P, Dugel PU, Holz FG, Weber M, Danis RP, Kuppermann BD, Bailey C, Billman K, Kapik B, Kane F, Green K; FAME Study Group. Cunha-Vaz J, et al. Among authors: billman k. Ophthalmology. 2014 Oct;121(10):1892-903. doi: 10.1016/j.ophtha.2014.04.019. Epub 2014 Jun 14. Ophthalmology. 2014. PMID: 24935282 Free article. Clinical Trial.
Sustained ocular delivery of fluocinolone acetonide by an intravitreal insert.
Campochiaro PA, Hafiz G, Shah SM, Bloom S, Brown DM, Busquets M, Ciulla T, Feiner L, Sabates N, Billman K, Kapik B, Green K, Kane F; Famous Study Group. Campochiaro PA, et al. Among authors: billman k. Ophthalmology. 2010 Jul;117(7):1393-9.e3. doi: 10.1016/j.ophtha.2009.11.024. Epub 2010 Mar 3. Ophthalmology. 2010. PMID: 20202684 Clinical Trial.
Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implants.
Campochiaro PA, Nguyen QD, Hafiz G, Bloom S, Brown DM, Busquets M, Ciulla T, Feiner L, Sabates N, Billman K, Kapik B, Green K, Kane FE; FAMOUS Study Group. Campochiaro PA, et al. Among authors: billman k. Ophthalmology. 2013 Mar;120(3):583-587. doi: 10.1016/j.ophtha.2012.09.014. Epub 2012 Dec 4. Ophthalmology. 2013. PMID: 23218184 Clinical Trial.
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema.
Campochiaro PA, Brown DM, Pearson A, Chen S, Boyer D, Ruiz-Moreno J, Garretson B, Gupta A, Hariprasad SM, Bailey C, Reichel E, Soubrane G, Kapik B, Billman K, Kane FE, Green K; FAME Study Group. Campochiaro PA, et al. Among authors: billman k. Ophthalmology. 2012 Oct;119(10):2125-32. doi: 10.1016/j.ophtha.2012.04.030. Epub 2012 Jun 21. Ophthalmology. 2012. PMID: 22727177 Clinical Trial.
White light laser.
Leonard ET, Yaffee MA, Billman KW. Leonard ET, et al. Among authors: billman kw. Appl Opt. 1970 May 1;9(5):1209. doi: 10.1364/AO.9.001209. Appl Opt. 1970. PMID: 20076351 No abstract available.
14 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page